Case Report
Copyright ©The Author(s) 2022.
World J Clin Cases. Sep 16, 2022; 10(26): 9454-9461
Published online Sep 16, 2022. doi: 10.12998/wjcc.v10.i26.9454
Figure 1
Figure 1 Pathologic examination of cervical embryonal rhabdomyosarcoma. A: Lower power view of the tumor cells; B: Higher power view of the tumor cells; C: Cartilage component (200 ×); D: Primitive stellate cells (200 ×).
Figure 2
Figure 2 Magnetic resonance imaging of the pelvis before and after neoadjuvant chemotherapy. A: The initial cervical mass size was about 5 cm; B: After neoadjuvant chemotherapy, the tumor size was reduced to 3 cm.
Figure 3
Figure 3  Gross appearance of the resected cervical tumor. The neoplasm infiltrates the cervical walls and grows in a polypoid fashion in the posterior cervical lip.
Figure 4
Figure 4 Immunohistochemistry showed in the tumor cells cytoplasmic positivity for Desmin, MyoD1, Myogenin, and WT-1. A: Desmin; B: MyoD1; C: Myogenin; D: WT1.